APO Research
Talk to an analyst

APO RESEARCH · REPORT

Guanfacine Extended-Release Pill

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Guanfacine Extended-Release Pill Industry Growth and Trends Forecast to 2032

2 January 202672 pages

Choose your research edition.

Industry ResearchGuanfacine Extended-Release Pill Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Guanfacine Extended-Release Pill Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Guanfacine Extended-Release Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Guanfacine Extended-Release Pill Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Guanfacine Extended-Release Pill Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Guanfacine Extended-Release Pill market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Guanfacine Extended-Release Pill is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Guanfacine Extended-Release Pill is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Guanfacine Extended-Release Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Guanfacine Extended-Release Pill include APOTEX, Shire Pharmaceuticals, TEVA Generics and TWi Pharmaceuticals USA, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Guanfacine Extended-Release Pill market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Guanfacine Extended-Release Pill market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Guanfacine Extended-Release Pill market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Guanfacine Extended-Release Pill.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Guanfacine Extended-Release Pill market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Guanfacine Extended-Release Pill Market by Company

APOTEX

Shire Pharmaceuticals

TEVA Generics

TWi Pharmaceuticals USA, Inc.

Guanfacine Extended-Release Pill Segment by Type

1mg/Pill

2mg/Pill

Guanfacine Extended-Release Pill Segment by Application

Inattention in Children

Children's Emotional Impulse

Guanfacine Extended-Release Pill Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Guanfacine Extended-Release Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Guanfacine Extended-Release Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Guanfacine Extended-Release Pill.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Guanfacine Extended-Release Pill manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Guanfacine Extended-Release Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg/Pill Table 2. Major Company of 2mg/Pill Table 3. Global Guanfacine Extended-Release Pill Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 5. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Type (2021-2026) Table 6. Global Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 7. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Type (2021-2026) Table 8. Global Guanfacine Extended-Release Pill Price by Type (2021-2026) & (US$/Unit) Table 9. Global Guanfacine Extended-Release Pill Sales by Type (2027-2032) & (K Units) Table 10. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Type (2027-2032) Table 11. Global Guanfacine Extended-Release Pill Sales by Type (2027-2032) & (US$ Million) Table 12. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Type (2027-2032) Table 13. Global Guanfacine Extended-Release Pill Price by Type (2027-2032) & (US$/Unit) Table 14. North America Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 15. North America Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 17. Europe Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 21. Latin America Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Guanfacine Extended-Release Pill Sales by Type (2021-2026) & (US$ Million) Table 24. Guanfacine Extended-Release Pill Industry Trends Table 25. Guanfacine Extended-Release Pill Industry Drivers Table 26. Guanfacine Extended-Release Pill Industry Opportunities and Challenges Table 27. Guanfacine Extended-Release Pill Industry Restraints Table 28. Global Guanfacine Extended-Release Pill Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Guanfacine Extended-Release Pill Revenue Market Share by Company (2021-2026) Table 30. Global Guanfacine Extended-Release Pill Sales by Company (2021-2026) & (K Units) Table 31. Global Guanfacine Extended-Release Pill Sales Share by Company (2021-2026) Table 32. Global Guanfacine Extended-Release Pill Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Guanfacine Extended-Release Pill Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Guanfacine Extended-Release Pill Major Company Production Sites and Headquarters Table 35. Global Guanfacine Extended-Release Pill Company, Product Type & Application Table 36. Global Guanfacine Extended-Release Pill Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Guanfacine Extended-Release Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Guanfacine Extended-Release Pill Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Guanfacine Extended-Release Pill Sales by Region (2021-2026) & (K Units) Table 41. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2021-2026) Table 42. Global Guanfacine Extended-Release Pill Sales by Region (2021-2026) & (US$ Million) Table 43. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2021-2026) Table 44. Global Guanfacine Extended-Release Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Guanfacine Extended-Release Pill Sales by Region (2027-2032) & (K Units) Table 46. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Region (2027-2032) Table 47. Global Guanfacine Extended-Release Pill Sales by Region (2027-2032) & (US$ Million) Table 48. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Region (2027-2032) Table 49. Global Guanfacine Extended-Release Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Guanfacine Extended-Release Pill Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 52. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Application (2021-2026) Table 53. Global Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 54. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Application (2021-2026) Table 55. Global Guanfacine Extended-Release Pill Price by Application (2021-2026) & (US$/Unit) Table 56. Global Guanfacine Extended-Release Pill Sales by Application (2027-2032) & (K Units) Table 57. Global Guanfacine Extended-Release Pill Sales Market Share in Volume by Application (2027-2032) Table 58. Global Guanfacine Extended-Release Pill Sales by Application (2027-2032) & (US$ Million) Table 59. Global Guanfacine Extended-Release Pill Sales Market Share in Value by Application (2027-2032) Table 60. Global Guanfacine Extended-Release Pill Price by Application (2027-2032) & (US$/Unit) Table 61. North America Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 62. North America Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 64. Europe Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 68. Latin America Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Guanfacine Extended-Release Pill Sales by Application (2021-2026) & (US$ Million) Table 71. APOTEX Company Information Table 72. APOTEX Business Overview Table 73. APOTEX Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. APOTEX Guanfacine Extended-Release Pill Product Portfolio Table 75. APOTEX Recent Development Table 76. Shire Pharmaceuticals Company Information Table 77. Shire Pharmaceuticals Business Overview Table 78. Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shire Pharmaceuticals Guanfacine Extended-Release Pill Product Portfolio Table 80. Shire Pharmaceuticals Recent Development Table 81. TEVA Generics Company Information Table 82. TEVA Generics Business Overview Table 83. TEVA Generics Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. TEVA Generics Guanfacine Extended-Release Pill Product Portfolio Table 85. TEVA Generics Recent Development Table 86. TWi Pharmaceuticals USA, Inc. Company Information Table 87. TWi Pharmaceuticals USA, Inc. Business Overview Table 88. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Product Portfolio Table 90. TWi Pharmaceuticals USA, Inc. Recent Development Table 91. North America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Guanfacine Extended-Release Pill Sales by Country (2021-2026) & (K Units) Table 93. North America Guanfacine Extended-Release Pill Sales Market Share by Country (2021-2026) Table 94. North America Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Guanfacine Extended-Release Pill Sales Market Share Forecast by Country (2027-2032) Table 96. North America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Guanfacine Extended-Release Pill Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Guanfacine Extended-Release Pill Market Share by Country (2021-2026) Table 99. North America Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Guanfacine Extended-Release Pill Market Share Forecast by Country (2027-2032) Table 101. Europe Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Guanfacine Extended-Release Pill Sales by Country (2021-2026) & (K Units) Table 103. Europe Guanfacine Extended-Release Pill Sales Market Share by Country (2021-2026) Table 104. Europe Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Guanfacine Extended-Release Pill Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Guanfacine Extended-Release Pill Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Guanfacine Extended-Release Pill Market Share by Country (2021-2026) Table 109. Europe Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Guanfacine Extended-Release Pill Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Guanfacine Extended-Release Pill Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Guanfacine Extended-Release Pill Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Guanfacine Extended-Release Pill Market Share by Country (2021-2026) Table 119. Asia-Pacific Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Guanfacine Extended-Release Pill Market Share Forecast by Country (2027-2032) Table 121. Latin America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Guanfacine Extended-Release Pill Sales by Country (2021-2026) & (K Units) Table 123. Latin America Guanfacine Extended-Release Pill Sales Market Share by Country (2021-2026) Table 124. Latin America Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Guanfacine Extended-Release Pill Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Guanfacine Extended-Release Pill Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Guanfacine Extended-Release Pill Market Share by Country (2021-2026) Table 129. Latin America Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Guanfacine Extended-Release Pill Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Guanfacine Extended-Release Pill Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Guanfacine Extended-Release Pill Market Share by Country (2021-2026) Table 139. Middle East and Africa Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Guanfacine Extended-Release Pill Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Guanfacine Extended-Release Pill Distributors List Table 144. Guanfacine Extended-Release Pill Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Guanfacine Extended-Release Pill Image Figure 2. Global Guanfacine Extended-Release Pill Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Guanfacine Extended-Release Pill Market Size (2021-2032) & (US$ Million) Figure 4. Global Guanfacine Extended-Release Pill Sales (2021-2032) & (K Units) Figure 5. 1mg/Pill Image Figure 6. Global 1mg/Pill Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2mg/Pill Image Figure 8. Global 2mg/Pill Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Guanfacine Extended-Release Pill Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Guanfacine Extended-Release Pill Market Share by Type 2025 VS 2032 Figure 11. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2025 Figure 12. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2025 Figure 13. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2025 Figure 14. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2025 Figure 17. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Guanfacine Extended-Release Pill Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Inattention in Children Image Figure 24. Global Inattention in Children Sales YoY Growth (2021-2032) & (K Units) Figure 25. Children's Emotional Impulse Image Figure 26. Global Children's Emotional Impulse Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Guanfacine Extended-Release Pill Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Guanfacine Extended-Release Pill Market Share by Application 2025 VS 2032 Figure 29. North America Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2025 Figure 30. North America Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2025 Figure 31. Europe Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2025 Figure 32. Europe Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2025 Figure 35. Latin America Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Guanfacine Extended-Release Pill Sales Market Share in Value by Application in 2025 Figure 39. North America Guanfacine Extended-Release Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Guanfacine Extended-Release Pill Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Guanfacine Extended-Release Pill Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Guanfacine Extended-Release Pill Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Guanfacine Extended-Release Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Guanfacine Extended-Release Pill Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Guanfacine Extended-Release Pill Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Guanfacine Extended-Release Pill Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Guanfacine Extended-Release Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Guanfacine Extended-Release Pill Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Guanfacine Extended-Release Pill Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Guanfacine Extended-Release Pill Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Guanfacine Extended-Release Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Guanfacine Extended-Release Pill Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Guanfacine Extended-Release Pill Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Guanfacine Extended-Release Pill Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Guanfacine Extended-Release Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Guanfacine Extended-Release Pill Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Guanfacine Extended-Release Pill Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Guanfacine Extended-Release Pill Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Guanfacine Extended-Release Pill Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Guanfacine Extended-Release Pill Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg/Pill
  • 2mg/Pill
Applications
  • Inattention in Children
  • Children's Emotional Impulse
Companies covered
  • APOTEX
  • Shire Pharmaceuticals
  • TEVA Generics
  • TWi Pharmaceuticals USA, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Guanfacine Extended-Release Pill Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Guanfacine Extended-Release Pill Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Guanfacine Extended-Release Pill Market by Type
  6. 1.3.1 1mg/Pill
  7. 1.3.2 2mg/Pill
  8. 1.4 Global Guanfacine Extended-Release Pill Market Size by Type
  9. 1.4.1 Global Guanfacine Extended-Release Pill Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Guanfacine Extended-Release Pill Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Guanfacine Extended-Release Pill Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Guanfacine Extended-Release Pill Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Guanfacine Extended-Release Pill Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Guanfacine Extended-Release Pill Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Guanfacine Extended-Release Pill Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Guanfacine Extended-Release Pill Industry Trends
  2. 2.2 Guanfacine Extended-Release Pill Industry Drivers
  3. 2.3 Guanfacine Extended-Release Pill Industry Opportunities and Challenges
  4. 2.4 Guanfacine Extended-Release Pill Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Guanfacine Extended-Release Pill Revenue (2021-2026)
  2. 3.2 Global Top Players by Guanfacine Extended-Release Pill Sales (2021-2026)
  3. 3.3 Global Top Players by Guanfacine Extended-Release Pill Price (2021-2026)
  4. 3.4 Global Guanfacine Extended-Release Pill Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Guanfacine Extended-Release Pill Major Company Production Sites & Headquarters
  6. 3.6 Global Guanfacine Extended-Release Pill Company, Product Type & Application
  7. 3.7 Global Guanfacine Extended-Release Pill Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Guanfacine Extended-Release Pill Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Guanfacine Extended-Release Pill Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Guanfacine Extended-Release Pill Tier 1, Tier 2, and Tier 3
4 Guanfacine Extended-Release Pill Regional Status and Outlook
  1. 4.1 Global Guanfacine Extended-Release Pill Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Guanfacine Extended-Release Pill Historic Market Size by Region
  3. 4.2.1 Global Guanfacine Extended-Release Pill Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Guanfacine Extended-Release Pill Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Guanfacine Extended-Release Pill Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Region
  7. 4.3.1 Global Guanfacine Extended-Release Pill Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Guanfacine Extended-Release Pill Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Guanfacine Extended-Release Pill Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Guanfacine Extended-Release Pill by Application
  1. 5.1 Guanfacine Extended-Release Pill Market by Application
  2. 5.1.1 Inattention in Children
  3. 5.1.2 Children's Emotional Impulse
  4. 5.2 Global Guanfacine Extended-Release Pill Market Size by Application
  5. 5.2.1 Global Guanfacine Extended-Release Pill Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Guanfacine Extended-Release Pill Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Guanfacine Extended-Release Pill Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Guanfacine Extended-Release Pill Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Guanfacine Extended-Release Pill Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Guanfacine Extended-Release Pill Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Guanfacine Extended-Release Pill Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Guanfacine Extended-Release Pill Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 APOTEX
  2. 6.1.1 APOTEX Company Information
  3. 6.1.2 APOTEX Business Overview
  4. 6.1.3 APOTEX Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 APOTEX Guanfacine Extended-Release Pill Product Portfolio
  6. 6.1.5 APOTEX Recent Developments
  7. 6.2 Shire Pharmaceuticals
  8. 6.2.1 Shire Pharmaceuticals Company Information
  9. 6.2.2 Shire Pharmaceuticals Business Overview
  10. 6.2.3 Shire Pharmaceuticals Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shire Pharmaceuticals Guanfacine Extended-Release Pill Product Portfolio
  12. 6.2.5 Shire Pharmaceuticals Recent Developments
  13. 6.3 TEVA Generics
  14. 6.3.1 TEVA Generics Company Information
  15. 6.3.2 TEVA Generics Business Overview
  16. 6.3.3 TEVA Generics Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TEVA Generics Guanfacine Extended-Release Pill Product Portfolio
  18. 6.3.5 TEVA Generics Recent Developments
  19. 6.4 TWi Pharmaceuticals USA, Inc.
  20. 6.4.1 TWi Pharmaceuticals USA, Inc. Company Information
  21. 6.4.2 TWi Pharmaceuticals USA, Inc. Business Overview
  22. 6.4.3 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 TWi Pharmaceuticals USA, Inc. Guanfacine Extended-Release Pill Product Portfolio
  24. 6.4.5 TWi Pharmaceuticals USA, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Guanfacine Extended-Release Pill Sales by Country
  2. 7.1.1 North America Guanfacine Extended-Release Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Guanfacine Extended-Release Pill Sales by Country (2021-2026)
  4. 7.1.3 North America Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032)
  5. 7.2 North America Guanfacine Extended-Release Pill Market Size by Country
  6. 7.2.1 North America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Guanfacine Extended-Release Pill Market Size by Country (2021-2026)
  8. 7.2.3 North America Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Guanfacine Extended-Release Pill Sales by Country
  2. 8.1.1 Europe Guanfacine Extended-Release Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Guanfacine Extended-Release Pill Sales by Country (2021-2026)
  4. 8.1.3 Europe Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Guanfacine Extended-Release Pill Market Size by Country
  6. 8.2.1 Europe Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Guanfacine Extended-Release Pill Market Size by Country (2021-2026)
  8. 8.2.3 Europe Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Guanfacine Extended-Release Pill Sales by Country
  2. 9.1.1 Asia-Pacific Guanfacine Extended-Release Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Guanfacine Extended-Release Pill Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Guanfacine Extended-Release Pill Market Size by Country
  6. 9.2.1 Asia-Pacific Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Guanfacine Extended-Release Pill Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Guanfacine Extended-Release Pill Sales by Country
  2. 10.1.1 South America Guanfacine Extended-Release Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Guanfacine Extended-Release Pill Sales by Country (2021-2026)
  4. 10.1.3 South America Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032)
  5. 10.2 South America Guanfacine Extended-Release Pill Market Size by Country
  6. 10.2.1 South America Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Guanfacine Extended-Release Pill Market Size by Country (2021-2026)
  8. 10.2.3 South America Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Guanfacine Extended-Release Pill Sales by Country
  2. 11.1.1 Middle East and Africa Guanfacine Extended-Release Pill Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Guanfacine Extended-Release Pill Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Guanfacine Extended-Release Pill Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Guanfacine Extended-Release Pill Market Size by Country
  6. 11.2.1 Middle East and Africa Guanfacine Extended-Release Pill Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Guanfacine Extended-Release Pill Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Guanfacine Extended-Release Pill Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Guanfacine Extended-Release Pill Value Chain Analysis
  2. 12.1.1 Guanfacine Extended-Release Pill Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Guanfacine Extended-Release Pill Production Mode & Process
  7. 12.2 Guanfacine Extended-Release Pill Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Guanfacine Extended-Release Pill Distributors
  10. 12.2.3 Guanfacine Extended-Release Pill Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst